Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NC › THOMASVILLE › THOMASVILLE-ARCHDALE PEDIATRICS, PLLC

THOMASVILLE-ARCHDALE PEDIATRICS, PLLC

NPI: 1427018894 · THOMASVILLE, NC 27360 · Pediatrics Physician · NPI assigned 03/28/2006

$41.91M
Total Medicaid Paid
1,846,803
Total Claims
1,385,293
Beneficiaries
99
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialTAYLOR, CLINT (MEDICAL PRACTICE ADMINISTRATOR)
NPI Enumeration Date03/28/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 133,415 $4.14M
2019 140,023 $5.24M
2020 104,437 $3.93M
2021 225,954 $5.86M
2022 402,961 $7.56M
2023 390,915 $7.23M
2024 449,098 $7.95M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 187,872 167,811 $11.75M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 77,628 68,700 $7.14M
99199 Unlisted special service, procedure or report 947,582 582,895 $5.97M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 27,642 24,701 $2.56M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 24,808 22,046 $2.27M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 24,149 21,530 $2.11M
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 91,430 81,455 $1.79M
90472 Immunization administration, each additional vaccine (list separately) 50,863 45,289 $1.53M
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 14,629 12,850 $1.45M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 5,817 5,682 $794K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 23,462 21,092 $685K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 12,312 9,944 $597K
D0145 Oral evaluation for a patient under three years of age 13,038 11,930 $466K
96110 Developmental screening, with scoring and documentation, per standardized instrument 45,374 40,644 $433K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 38,820 34,825 $358K
87276 15,437 13,256 $210K
87275 15,423 13,240 $209K
D1206 Topical application of fluoride varnish 13,041 11,931 $206K
90474 7,887 7,087 $154K
99050 5,657 5,197 $144K
99215 Prolong outpt/office vis 1,034 983 $125K
96127 27,526 24,001 $120K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 7,468 7,067 $102K
99070 9,349 8,923 $82K
90651 4,429 3,815 $78K
54150 228 216 $72K
80061 Lipid panel 2,365 2,118 $38K
96161 9,919 8,848 $35K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,954 1,779 $35K
87070 3,409 3,345 $35K
90686 24,819 21,757 $32K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,414 1,232 $25K
92551 16,270 14,718 $23K
99051 869 815 $22K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 574 518 $20K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 499 446 $18K
99173 23,632 21,332 $16K
90734 770 747 $16K
0072A 310 218 $16K
99401 530 360 $15K
0071A 291 225 $15K
0001A 285 204 $15K
87807 953 849 $13K
0002A 247 152 $11K
83036 Hemoglobin; glycosylated (A1C) 826 735 $10K
90620 377 349 $10K
87086 Culture, bacterial; quantitative colony count, urine 910 820 $9K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 869 834 $9K
83655 504 489 $7K
90619 1,485 1,147 $7K
81002 2,411 2,218 $7K
99239 Hospital discharge day management, more than 30 minutes 68 68 $6K
81025 560 547 $4K
97802 41 39 $3K
36415 Collection of venous blood by venipuncture 928 890 $2K
94664 208 196 $2K
A4627 Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler 55 48 $2K
90715 556 470 $2K
82947 357 297 $2K
E0570 Nebulizer, with compressor 13 12 $2K
99462 56 56 $2K
90656 1,565 1,510 $2K
90633 3,406 3,092 $1K
99381 14 12 $1K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 15 12 $1K
0124A 18 12 $1K
96380 63 62 $1K
99058 56 54 $922.60
99460 13 13 $655.07
J0696 Injection, ceftriaxone sodium, per 250 mg 215 200 $626.66
91300 984 642 $195.00
90744 2,982 2,661 $146.78
90716 280 247 $124.91
90698 9,465 8,522 $106.70
86580 22 14 $86.72
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 15 15 $55.70
94760 4,477 4,216 $44.75
36416 16 12 $6.16
90671 2,885 2,693 $5.81
94761 13 12 $3.49
90680 7,938 7,145 $0.47
90670 12,273 10,985 $0.09
90700 1,951 1,784 $0.03
90710 161 144 $0.02
91307 955 678 $0.00
99000 373 371 $0.00
J7609 Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg 547 518 $0.00
3008F 393 353 $0.00
J8540 Dexamethasone, oral, 0.25 mg 455 437 $0.00
90381 13 13 $0.00
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 12 12 $0.00
90685 1,192 1,169 $0.00
J2405 Injection, ondansetron hydrochloride, per 1 mg 726 702 $0.00
90713 168 153 $0.00
90707 242 211 $0.00
J1050 Injection, medroxyprogesterone acetate, 1 mg 540 533 $0.00
90648 82 63 $0.00
91312 18 12 $0.00
90380 21 21 $0.00